500
0
0

November is Lung Cancer Awareness Month. Explore both sides of lung cancer diagnosis →

Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
🔍
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Annual Reports
SCLC Report
Policy and resources
English
Our Members
🔍
Folder: Who We Are
Back
Overview
Contact
Our Board
Newsletter
Brand hub
Our Partners
Supporters & Funding
Folder: Reports
Back
Annual Reports
SCLC Report
Policy and resources
English
Back
Our Members
No results found
Lung Cancer Europe and members, Access to treatment Web Team 30/04/2026 Lung Cancer Europe and members, Access to treatment Web Team 30/04/2026

How Athena. Women Against Cancer Keep Fighting for Lung Cancer Access in Ukraine

Read More
Lung Cancer Europe and members Web Team 30/04/2026 Lung Cancer Europe and members Web Team 30/04/2026

We Are Looking for People Affected by Lung Cancer to Join Our New Advisory Board

Read More
Policy and EU affairs, Access to treatment Web Team 30/04/2026 Policy and EU affairs, Access to treatment Web Team 30/04/2026

How the EU HTA Regulation is Changing Lung Cancer Treatment Assessment in Europe

Read More
Policy and EU affairs Web Team 27/04/2026 Policy and EU affairs Web Team 27/04/2026

Why Lung Cancer Europe Is Supporting the WECAN Open Letter on the EU Budget

Why Lung Cancer Europe co-signed an open letter from 23 European cancer organisations asking the EU not to sideline cancer in its 2028 to 2034 budget.

Read More
Lung Cancer Europe and members Web Team 22/04/2026 Lung Cancer Europe and members Web Team 22/04/2026

“We Are an Organisation That Moves”: Debra Montague Opens the Inaugural Lung Cancer Europe Conference

Read More
Treatment and research, Biomarkers and diagnosis Web Team 20/04/2026 Treatment and research, Biomarkers and diagnosis Web Team 20/04/2026

A lung cancer mutation that has resisted treatment for decades may finally have a drug

Read More
Biomarkers and diagnosis, Access to treatment Web Team 18/04/2026 Biomarkers and diagnosis, Access to treatment Web Team 18/04/2026

Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece

Read More
Screening and early diagnosis Web Team 14/04/2026 Screening and early diagnosis Web Team 14/04/2026

AI That Sees Lung Scans the Way a Radiologist Does

Read More
Treatment and research Web Team 10/04/2026 Treatment and research Web Team 10/04/2026

Why does lung cancer so often spread to the brain?

Read More
Screening and early diagnosis Web Team 08/04/2026 Screening and early diagnosis Web Team 08/04/2026

Lung cancer screening detects other cancers too, new research finds

Read More
Lung Cancer Europe and members Web Team 06/04/2026 Lung Cancer Europe and members Web Team 06/04/2026

Lung Cancer Europe welcomes a new member organisation from Kosovo

Read More
Prevention and risk Web Team 05/04/2026 Prevention and risk Web Team 05/04/2026

Can vaping cause lung cancer? What the latest evidence says

Read More
Biomarkers and diagnosis Web Team 02/04/2026 Biomarkers and diagnosis Web Team 02/04/2026

Why biomarker testing should be routine in all NSCLC

Read More
Screening and early diagnosis Web Team 01/04/2026 Screening and early diagnosis Web Team 01/04/2026

Germany launches lung cancer screening programme from 1 April

Read More
Treatment and research, Access to treatment Web Team 31/03/2026 Treatment and research, Access to treatment Web Team 31/03/2026

EMA recommends tarlatamab for relapsed extensive-stage SCLC

Read More
Lung Cancer Europe and members Web Team 31/03/2026 Lung Cancer Europe and members Web Team 31/03/2026

Lung Cancer Europe publishes 2025 End of Year Report

Read More
Lung Cancer Europe and members Web Team 30/03/2026 Lung Cancer Europe and members Web Team 30/03/2026

Three more speakers announced for the Lung Cancer Europe Conference 2026

Read More
Living with lung cancer, Lung Cancer Europe and members Web Team 27/03/2026 Living with lung cancer, Lung Cancer Europe and members Web Team 27/03/2026

10 Country Reports on Lung Cancer and Mental Health Now Available

Read More
Living with lung cancer, Lung Cancer Europe and members Web Team 27/03/2026 Living with lung cancer, Lung Cancer Europe and members Web Team 27/03/2026

Lung Cancer and Mental Health: Evidence for Change from the 11th Lung Cancer Europe Report

Read More
Living with lung cancer Web Team 26/03/2026 Living with lung cancer Web Team 26/03/2026

Small Cell Lung Cancer report released alongside Lung Cancer Europe’s 11th Report on mental health

Read More
Newer Posts
Older Posts

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on the 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

Sign up to our newsletter

PRIVACY POLICY
COMPLIANCE

© Lung Cancer Europe 2026 | Designed by Laura Jones